The UBS Global Life Sciences Conference opens today at the Grand Hyatt in New York City and runs through Thursday, September 28. The Conference will feature presentations by more than 340 public and private companies representing biotechnology, medical device manufacturers, pharmaceuticals and specialty pharmaceutical.
The annual UBS Global Life Sciences Conference is among the largest health care investor conferences in the world. Senior executives from the leading pharmaceutical, biotechnology and medical technology companies will provide their insight and outlook on the global life sciences industry. More than 3,500 people are expected to attend.
Presenting companies include:
Abraxis Bioscience
Actelion Ltd
Actavis
Advanced Medical Optics, Inc.
Agilent Technologies, Inc.
Amylin Pharmaceuticals Inc.
Applied Biosystems Group
Beckman Coulter, Inc.
Biogen IDEC Inc.
Bio-Rad Laboratories
Biovail Corporation
Caremark Rx. Inc.
Celgene Corp.
Charles River Laboratories International Inc.
Covance Inc.
DENTSPLY International Inc.
Edwards Lifesciences Corp.
Endo Pharmaceuticals Holdings Inc.
Fresenius AG
Genentech Inc.
Gen-Probe Inc.
Genzyme Corporation
Gilead Sciences, Inc.
Hologic Inc.
ICOS Corp.
Illumina, Inc.
IMS Health
Intuitive Surgical, Inc.
Invitrogen Corporation
Ipsen
Kos Pharmaceuticals
Laboratory Corporation of America Holdings
MDS International
Medicis Pharmaceuticals
MedImmune, Inc.
Medtronic
Mentor Corporation
Mettler-Toledo International Inc.
Millennium Pharmaceuticals
Millipore Corporation
Myogen
Nobel Biocare
Novartis AG
OSI Pharmaceuticals
PerkinElmer, Inc.
Pfizer
Pharmaceutical Product Development
Progenics
Protein Design Labs, Inc.
QIAGEN NV
Quest Diagnostics Incorporated
Respironics
Roche Holdings AG
Schwarz Pharma AG
Shire Pharmaceuticals
Sigma-Aldrich
Sirona Dental Systems
Stericycle Inc.
Steris Corp.
Straumann AG
Stryker
Synthes Inc.
Telik
Teva Pharmaceuticals
Thermo Electron Corporation
United Therapeutics
Varian Inc.
Vertex Pharmaceuticals
Waters Corporation
Wyeth
Comments